June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Knocking Down p75NTR Expression Prevents Retinal Acellular Capillary Formation In ProNGF-Overexpression Model.
Author Affiliations & Notes
  • Ahmed Shanab
    Clinical and Experimental Therapeutic, University of Georgia, Augusta, GA
    Vision Discovery Institute, Georgia Health Science University, Augusta, GA
  • Barbara Mysona
    Clinical and Experimental Therapeutic, University of Georgia, Augusta, GA
    Vision Discovery Institute, Georgia Health Science University, Augusta, GA
  • Suraporn Matragoon
    Clinical and Experimental Therapeutic, University of Georgia, Augusta, GA
    VA Medical Center, Charlie Norwood Veterans Affairs Medical Center, Augusta, GA
  • Azza El-Remessy
    Clinical and Experimental Therapeutic, University of Georgia, Augusta, GA
    Vision Discovery Institute, Georgia Health Science University, Augusta, GA
  • Footnotes
    Commercial Relationships Ahmed Shanab, None; Barbara Mysona, None; Suraporn Matragoon, None; Azza El-Remessy, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5606. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ahmed Shanab, Barbara Mysona, Suraporn Matragoon, Azza El-Remessy; Knocking Down p75NTR Expression Prevents Retinal Acellular Capillary Formation In ProNGF-Overexpression Model.. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5606. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: We have previously shown significant accumulation of the pro-form of nerve growth factor (proNGF) and its receptor p75NTR in diabetic rat retinas. Stable overexpression of proNGF induced acellular capillaries in rat retina. Recent studies showed that modulating p75NTR expression mitigates proNGF-mediated release of inflammatory mediators in Muller cells and diabetic retina. Although the link between retinal inflammation and vascular injury has been well-established, the role of p75NTR remains unexplored. The aim of this study is to elucidate the role and mechanism by which knocking down expression of p75NTR can prevent development of acellular capillaries, a hall mark of diabetic retinopathy, in vivo.

Methods: Overexpression of proNGF in SD rats was achieved by intravitreal injection of the GFP-proNGF123 plasmid (20 μg). Expression of p75NTR was silenced using co-intravitreal injection of shRNA for 6-weeks. Expression of NGF, proNGF, p75NTR and apoptotic markers was quantified by Western-Blot. Acellular capillary formation was detected in retinal trypsine digest. Human retinal endothelial cells were cultured in high glucose and stimulated with mutant proNGF and the interaction between p75NTR intracellular domain (ICDp75) and neurotrophin receptor interacting factor (NRIF) was examined using immunoprecipitation.

Results: Knocking down expression of p75NTR using shRNA significantly reduced proNGF- induced acellular capillary formation and the number of TUNEL-positive cells in retinal tryptic digest. Overexpression of proNGF induced significant increases of ICDp75 and decreased NGF expression compared with GFP or GFP-shRNA. In high glucose maintained endothelial cultures, proNGF accelerated endothelial apoptosis and stimulated expression of ICDp75 and its association with NRIF protein as indicated by immunoprecipitation.

Conclusions: Silencing p75NTR expression restored NGF levels and exerted vascular protective action in retina that stably overexpresses cleavage-resistant proNGF. P75-mediated apoptosis in retinal vascular endothelial cells involve recruitment of NRIF. Therefore, targeting p75NTR may be an effective strategy in treatment of diabetic retinopathy.

Keywords: 688 retina • 499 diabetic retinopathy • 449 cell survival  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×